In 2022, RoseTTAFold predicted the structures of neurodegenerative disease-related proteins such as tau and α-synuclein, shedding new light on the molecular basis of protein aggregation and its role in Alzheimer’s and Parkinson’s diseases (Šali and Blundell, 1993). The gene discussed is MAPT; the disease is neurodegenerative disease.